Temocapril prevents motor neuron damage and upregulation of cyclooxygenase-II in glutamate-induced neurotoxicity

Neurological Research

Volumn 25, Issue 3, 2003, Pages 301-304

  Iwasaki, Yasuo ^a   Ichikawa, Yasumitsu ^a   Igarashi, Osamu ^a   Ken Ikeda, ^a,b   Konno, Shingo ^a   Aoyagi, Joe ^a   Kinoshita, Masao ^a  

^a TOHO UNIVERSITY   (Japan)

^b PL Tokyo Health Care Center   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Cyclooxygenase II; Glutamate induced neurotoxicity; Neuroprotection; Temocapril

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CYCLOOXYGENASE 2; GLUTAMIC ACID; TEMOCAPRIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; EXCITOTOXICITY; MOTONEURON; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; ORGAN CULTURE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELL DEATH; CHOLINE O-ACETYLTRANSFERASE; CYCLOOXYGENASE 2; GLUTAMIC ACID; ISOENZYMES; MOTOR NEURON DISEASE; MOTOR NEURONS; ORGAN CULTURE TECHNIQUES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; THIAZEPINES; UP-REGULATION;

EID: 0037398801     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101201382     Document Type: Article

References (23)

1. Govantes C, Marin J. Effect of angiotensin-converting enzyme inhibitors on quality of life in hypertensive patients: Pharmacodynamic basis. Fundam Clin Pharmacol 1996; 10: 400-405
2. Sadoshima S, Fujii K, Ooboshi H, Ibayashi S, Fujishima M. Angiotensin-converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats. Stroke 1993; 24: 1561-1566
3. Fujii K, Weno BL, Baumbach GL, Heistad DD. Effect of antihypertensive treatment of focal cerebral infarction. Hypertension 1992; 19: 713-716
4. Lee RM, Wang H, Smeda JS. Perindepril treatment in the prevention of stroke in experimental animals. J Hypertens 1996; 14(Suppl.): 29-33
5. Werner C, Hoffmann WE, Kochs E, Rabito SF, Miletich DJ. Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke 1991; 22: 910-914
6. Diez J, Panizo A, Hernandez M, Vega F, Sola I, Fortuno MA, Pardo J. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 1997; 30: 1029-1034
7. Ravati A, Junker V, Kouklei M, Ablemeyer B, Culmsee C, Krieglstein J. Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. Eur J Pharmacol 1999; 373: 21-33
8. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med 1994; 330: 613-622
9. Coyle JT, Putfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695
10. Bredesen DE. Neural apoptosis. Ann Neurol 1995; 38: 839-851
11. Lacomblez L, Bensimon G, Leigh PN, Guilletg P, Meininger V. Dose-ranging study of ruluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425-1431
12. O'Banion MK. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999; 13: 45-82
13. Nogawa S, Zhang F, Ross ME, ladecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997; 17: 2746-2755
14. Bilak MM, Corse AM, Bilak SR, Lehar M, Tombran-Tink J, Kuncl RW. Pigment epitheliumn-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 1999; 58: 719-728
15. Shaw PJ. Excitotoxicity and motor neuron disease: A review of the evidence. J Neurol Sci 1984; 124(Suppl.): 6-13
16. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation. J Neurochem 1998; 51: 1960-1963
17. Anderson B, Khaper N, Dhalla AK, Signal PK. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts. Can J Cardiol 1996; 12: 1099-1104
18. Satoh H, Matsuki K. Electrical and mechanical modulations by oxygen-derived free radical generating systems in guinea pig heart muscles. J Pharm Pharmacol 1997; 49: 505-510
19. De Cavanagh EM, Fraga CG, Ferder L, Inserra F. Enalapril and captopril enhance antioxidant defences in mouse tissues. Am J Physiol 1997; 272: 514-518
20. Kaufmann W, Andreasson K, Isakson P, Worley P. Cyclo-oxygenases and the central nervous system. Prostaglandins 1997; 54: 601-624
21. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclo-oxygenase-2-deficient mice. Proc Natl Acad Sci USA 2001; 98: 1294-1299
22. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. Marked increase in cyclooxygenase-2 in ALS spinal cord. Implications for therapy. Neurology 2001; 57: 952-956
23. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S. Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001; 49: 176-185